The impact of a human IGF-II analog ([Leu(27)]IGF-II) on fetal growth in a mouse model of fetal growth restriction

Enhancing placental insulin-like growth factor (IGF) availability appears to be an attractive strategy for improving outcomes in fetal growth restriction (FGR). Our approach was the novel use of [Leu(27)]IGF-II, a human IGF-II analog that binds the IGF-II clearance receptor IGF-IIR in fetal growth-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Charnock, Jayne C., Dilworth, Mark R., Aplin, John D., Sibley, Colin P., Westwood, Melissa, Crocker, Ian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675800/
https://www.ncbi.nlm.nih.gov/pubmed/26530156
http://dx.doi.org/10.1152/ajpendo.00379.2015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675800/
https://www.ncbi.nlm.nih.gov/pubmed/26530156
http://dx.doi.org/10.1152/ajpendo.00379.2015

Ejemplares similares